- Home
- / e-therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
e-therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Total Funding
$66.8 M
CreditSafe Score
?
Score changed on Jun 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 44.0K | 456.0K | 317.0K | 477.0K | 475.0K | 318.0K | ||
| Gross profit | 44.0K | 456.0K | 317.0K | 477.0K | 475.0K | 318.0K | ||
| Gross profit margin, % | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |||
| Operating expense total | 6.7M | 5.1M | 423.0K | 4.7M | 9.8M | 10.7M | 14.1M | 18.6M |
| Depreciation and amortization | 72.0K | 73.0K | 2.9M | 112.0K | 218.0K | |||
| EBITDA | (6.7M) | (5.0M) | 33.0K | (4.4M) | (9.4M) | (10.2M) | (13.8M) | (18.6M) |
| EBITDA margin, % | 7.2% | -1379.5% | -1960.6% | -2155.6% | -4337.7% | |||
| EBIT | (6.8M) | (5.1M) | (2.9M) | (4.5M) | (9.6M) | (10.2M) | (13.8M) | (18.6M) |
| EBIT margin, % | -633.3% | -1414.8% | -2006.3% | -2155.6% | -4337.7% | |||
| Interest income | 49.0K | 29.0K | 15.0K | 17.0K | 61.0K | 242.0K | 740.0K | 1.1M |
| Interest expense | 10.0K | 23.0K | 27.0K | 47.0K | ||||
| Pre tax profit | (6.7M) | (5.1M) | (2.9M) | (4.5M) | (9.5M) | (9.8M) | (13.1M) | (17.6M) |
| Income tax expense | (1.4M) | (1.1M) | (526.0K) | (784.0K) | (1.4M) | (1.5M) | (1.9M) | (2.7M) |
| Net Income | (5.4M) | (4.0M) | (2.3M) | (3.7M) | (8.1M) | (8.3M) | (11.2M) | (14.9M) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |